
Nizal S. Chandrakumar
Examiner (ID: 111, Phone: (571)272-6202 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625 |
| Total Applications | 2819 |
| Issued Applications | 1922 |
| Pending Applications | 209 |
| Abandoned Applications | 730 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10045152
[patent_doc_number] => 09085541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-21
[patent_title] => 'Process for producing imine compounds for combating invertebrate pests'
[patent_app_type] => utility
[patent_app_number] => 13/805559
[patent_app_country] => US
[patent_app_date] => 2011-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40898
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805559
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/805559 | Process for producing imine compounds for combating invertebrate pests | Jun 21, 2011 | Issued |
Array
(
[id] => 9657570
[patent_doc_number] => 20140228575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'Process for the Preparation of Solifenacin and Salts Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/127572
[patent_app_country] => US
[patent_app_date] => 2011-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6156
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127572
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/127572 | Process for the Preparation of Solifenacin and Salts Thereof | Jun 21, 2011 | Abandoned |
Array
(
[id] => 8063371
[patent_doc_number] => 20110245338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/159738
[patent_app_country] => US
[patent_app_date] => 2011-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4403
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245338.pdf
[firstpage_image] =>[orig_patent_app_number] => 13159738
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/159738 | Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof | Jun 13, 2011 | Issued |
Array
(
[id] => 8780664
[patent_doc_number] => 20130102640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'METHOD FOR THE PREPARATION OF CIS-1,2-DIOLS IN THE KILOGRAM SCALE'
[patent_app_type] => utility
[patent_app_number] => 13/807796
[patent_app_country] => US
[patent_app_date] => 2011-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8084
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807796
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/807796 | METHOD FOR THE PREPARATION OF CIS-1,2-DIOLS IN THE KILOGRAM SCALE | Jun 2, 2011 | Abandoned |
Array
(
[id] => 8543508
[patent_doc_number] => 08318801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-27
[patent_title] => 'Cinnamic compounds and derivatives therefrom for the inhibition of histone deacetylase'
[patent_app_type] => utility
[patent_app_number] => 13/114619
[patent_app_country] => US
[patent_app_date] => 2011-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 10
[patent_no_of_words] => 15233
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13114619
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/114619 | Cinnamic compounds and derivatives therefrom for the inhibition of histone deacetylase | May 23, 2011 | Issued |
Array
(
[id] => 9575561
[patent_doc_number] => 08765976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-01
[patent_title] => 'Polymorphic forms of Warfarin potassium and preparations thereof'
[patent_app_type] => utility
[patent_app_number] => 13/699293
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5426
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699293
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/699293 | Polymorphic forms of Warfarin potassium and preparations thereof | May 19, 2011 | Issued |
Array
(
[id] => 6016711
[patent_doc_number] => 20110224192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => '3-Arylamino Pyridine Derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/112490
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28405
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224192.pdf
[firstpage_image] =>[orig_patent_app_number] => 13112490
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/112490 | 3-arylamino pyridine derivatives | May 19, 2011 | Issued |
Array
(
[id] => 10032515
[patent_doc_number] => 09073822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Process for producing compounds comprising nitrile functions'
[patent_app_type] => utility
[patent_app_number] => 13/699237
[patent_app_country] => US
[patent_app_date] => 2011-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4169
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699237
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/699237 | Process for producing compounds comprising nitrile functions | May 16, 2011 | Issued |
Array
(
[id] => 8909675
[patent_doc_number] => 08481739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-09
[patent_title] => '3,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinases'
[patent_app_type] => utility
[patent_app_number] => 13/108642
[patent_app_country] => US
[patent_app_date] => 2011-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76355
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13108642
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/108642 | 3,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinases | May 15, 2011 | Issued |
Array
(
[id] => 9271780
[patent_doc_number] => RE044734
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2014-01-28
[patent_title] => 'Process for the production of 3-oxo-pregn-4-ene-21,17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes'
[patent_app_type] => reissue
[patent_app_number] => 13/506373
[patent_app_country] => US
[patent_app_date] => 2011-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4163
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13506373
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/506373 | Process for the production of 3-oxo-pregn-4-ene-21,17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes | May 11, 2011 | Issued |
Array
(
[id] => 6089015
[patent_doc_number] => 20110217699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use'
[patent_app_type] => utility
[patent_app_number] => 13/104413
[patent_app_country] => US
[patent_app_date] => 2011-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15226
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20110217699.pdf
[firstpage_image] =>[orig_patent_app_number] => 13104413
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/104413 | Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use | May 9, 2011 | Abandoned |
Array
(
[id] => 8642842
[patent_doc_number] => 08367829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-05
[patent_title] => 'Bi-functional pyrazolopyridine compounds'
[patent_app_type] => utility
[patent_app_number] => 13/103598
[patent_app_country] => US
[patent_app_date] => 2011-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32139
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13103598
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/103598 | Bi-functional pyrazolopyridine compounds | May 8, 2011 | Issued |
Array
(
[id] => 9273752
[patent_doc_number] => 08637684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-28
[patent_title] => 'Tautomycetin and tautomycetin analog biosynthesis'
[patent_app_type] => utility
[patent_app_number] => 13/101612
[patent_app_country] => US
[patent_app_date] => 2011-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 31869
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13101612
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/101612 | Tautomycetin and tautomycetin analog biosynthesis | May 4, 2011 | Issued |
Array
(
[id] => 7720947
[patent_doc_number] => 20120010282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'Tautomycetin and Tautomycetin Analog Biosynthesis'
[patent_app_type] => utility
[patent_app_number] => 13/101624
[patent_app_country] => US
[patent_app_date] => 2011-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20191
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010282.pdf
[firstpage_image] =>[orig_patent_app_number] => 13101624
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/101624 | Tautomycetin and tautomycetin analog biosynthesis | May 4, 2011 | Issued |
Array
(
[id] => 8670627
[patent_doc_number] => 20130045165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => '4-FLUORO-4-ARYLPIPERDIN-1-YL DERIVATIVES AS MU OPIOID FUNCTION MODERATORS'
[patent_app_type] => utility
[patent_app_number] => 13/695065
[patent_app_country] => US
[patent_app_date] => 2011-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14745
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695065
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/695065 | 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators | Apr 28, 2011 | Issued |
Array
(
[id] => 8618203
[patent_doc_number] => 20130023515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'NOVEL SPIROPIPERIDINE PROLYLCARBOXYPEPTIDASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/638976
[patent_app_country] => US
[patent_app_date] => 2011-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30864
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13638976
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/638976 | Spiropiperidine prolylcarboxypeptidase inhibitors | Apr 20, 2011 | Issued |
Array
(
[id] => 9060146
[patent_doc_number] => 08546581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide'
[patent_app_type] => utility
[patent_app_number] => 13/087255
[patent_app_country] => US
[patent_app_date] => 2011-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5118
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13087255
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/087255 | Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide | Apr 13, 2011 | Issued |
Array
(
[id] => 8780652
[patent_doc_number] => 20130102627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'Acridines As Inhibitors Of Haspin And DYRK Kinases'
[patent_app_type] => utility
[patent_app_number] => 13/639569
[patent_app_country] => US
[patent_app_date] => 2011-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12431
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639569
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/639569 | Acridines As Inhibitors Of Haspin And DYRK Kinases | Apr 7, 2011 | Abandoned |
Array
(
[id] => 8214664
[patent_doc_number] => 08193360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging'
[patent_app_type] => utility
[patent_app_number] => 13/082215
[patent_app_country] => US
[patent_app_date] => 2011-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12532
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193360.pdf
[firstpage_image] =>[orig_patent_app_number] => 13082215
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/082215 | Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging | Apr 6, 2011 | Issued |
Array
(
[id] => 5959805
[patent_doc_number] => 20110184192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'PROSTAGLANDIN SYNTHESIS AND INTERMEDIATES FOR USE THEREIN'
[patent_app_type] => utility
[patent_app_number] => 13/081794
[patent_app_country] => US
[patent_app_date] => 2011-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3378
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20110184192.pdf
[firstpage_image] =>[orig_patent_app_number] => 13081794
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/081794 | Prostaglandin synthesis and intermediates for use therein | Apr 6, 2011 | Issued |